Shanghai Jiao Tong University (SJTU) School of Biomedical Engineering – Institute for Personalized Medicine (IPM) is co-funded by China Ministry of Science and Technology and China Ministry of Education. The institute focuses its research on personalized disease diagnostics and personalized disease therapeutics. The institute highly emphasizes multi-disciplinary fields including biomedical, engineering, biology, bioinformatics and computer science. Since 2004, majors at SJTU listed in ESI's top 0.01% have included engineering, materials, computer science, pharmacology, chemistry, etc. And majors at SJTU listed in ESI's top 0.1% have included biology, biochemistry, clinical medicine, molecular biology, microbiology, immunology, etc. The institute is highly international as well.
The institute is led by Prof. Chih-Ming Ho, who is a former vice-president of University of California Los Angeles (UCLA), a member of American Academy of Engineering, a member of Academia Sinica and a member of China “Top-People-plan”. The institute is currently carrying National “Major Drug Development Project”, Bill & Melinda Gates Foundation “HIV and TB new therapeutics development project” and more than 10 international personalized medicine related collaborations.